Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II Study of Tesetaxel Plus Capecitabine and Cisplatin in Subjects With Advanced Gastric Cancer

NCT01348009 is registered in ClinicalTrials.gov with Genta Incorporated as lead sponsor.

NCT NCT01348009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II Study of Tesetaxel Plus Capecitabine and Cisplatin in Subjects With Advanced Gastric Cancer
Lead sponsor
Genta Incorporated
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2011
Completion date
January 31, 2014
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric carcinoma